These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 27943425)
1. Efficacy, safety and drug survival of conventional agents in pediatric psoriasis: A multicenter, cohort study. Ergun T; Seckin Gencosmanoglu D; Alpsoy E; Bulbul-Baskan E; Saricam MH; Salman A; Onsun N; Sarioz A J Dermatol; 2017 Jun; 44(6):630-634. PubMed ID: 27943425 [TBL] [Abstract][Full Text] [Related]
2. Conventional therapies for psoriasis. Rebora A Reumatismo; 2007; 59 Suppl 1():77-80. PubMed ID: 17828351 [TBL] [Abstract][Full Text] [Related]
3. Safety of Systemic Agents for the Treatment of Pediatric Psoriasis. Bronckers IMGJ; Seyger MMB; West DP; Lara-Corrales I; Tollefson M; Tom WL; Hogeling M; Belazarian L; Zachariae C; Mahé E; Siegfried E; Philipp S; Szalai Z; Vleugels RA; Holland K; Murphy R; Baselga E; Cordoro K; Lambert J; Alexopoulos A; Mrowietz U; Kievit W; Paller AS; JAMA Dermatol; 2017 Nov; 153(11):1147-1157. PubMed ID: 28903160 [TBL] [Abstract][Full Text] [Related]
4. Concurrent use of methotrexate and acitretin revisited. Lowenthal KE; Horn PJ; Kalb RE J Dermatolog Treat; 2008; 19(1):22-6. PubMed ID: 18273721 [TBL] [Abstract][Full Text] [Related]
5. Combination of adalimumab with traditional systemic antipsoriatic drugs - a report of 39 cases. Philipp S; Wilsmann-Theis D; Weyergraf A; Rotterdam S; Frambach Y; Gerdes S; Mössner R J Dtsch Dermatol Ges; 2012 Nov; 10(11):821-37. PubMed ID: 22934607 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness and persistence of acitretin, ciclosporin, fumaric acid esters and methotrexate for patients with moderate-to-severe psoriasis: a cohort study from BADBIR. Alabas OA; Mason KJ; Yiu ZZN; Hampton PJ; Reynolds NJ; Owen CM; Bewley A; Laws PM; Warren RB; Lunt M; Smith CH; Griffiths CEM; Br J Dermatol; 2023 Apr; 188(5):618-627. PubMed ID: 36763783 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of combination Acitretin and Pioglitazone therapy in patients with moderate to severe chronic plaque-type psoriasis: a randomized, double-blind, placebo-controlled clinical trial. Mittal R; Malhotra S; Pandhi P; Kaur I; Dogra S Arch Dermatol; 2009 Apr; 145(4):387-93. PubMed ID: 19380660 [TBL] [Abstract][Full Text] [Related]
8. Biologics combined with conventional systemic agents for the treatment of children with severe psoriasis. Real-life data from the BiPe cohorts and a practice survey among French and Italian pediatric dermatologists. Mahé E; Beauchet A; Hadj-Rabia S; Mazereeuw-Hautier J; Mallet S; Phan A; Severino-Freire M; Boralevi F; Aubert H; Barthélémy H; Girard C; Martin L; Piram M; Barbarot S; Balguerie X; Zitouni J; Phan C; Di Lernia V; Dermatol Ther; 2022 Nov; 35(11):e15828. PubMed ID: 36107157 [TBL] [Abstract][Full Text] [Related]
9. The acitretin and methotrexate combination therapy for psoriasis vulgaris achieves higher effectiveness and less liver fibrosis. An J; Zhang D; Wu J; Li J; Teng X; Gao X; Li R; Wang X; Xia L; Xia Y Pharmacol Res; 2017 Jul; 121():158-168. PubMed ID: 28414177 [TBL] [Abstract][Full Text] [Related]
10. Moderate to severe plaque psoriasis - treatment with drugs of the classic scheme. Arnone M; Carvalho AVE; Takahashí MDF; Bernardo WM Rev Assoc Med Bras (1992); 2019 May; 65(4):530-534. PubMed ID: 31066805 [TBL] [Abstract][Full Text] [Related]
11. Psoriasis: state of the art 2013. de la Brassinne M; Nikkels A Acta Clin Belg; 2013; 68(6):433-41. PubMed ID: 24635331 [TBL] [Abstract][Full Text] [Related]
12. Factors associated with drug survival of methotrexate and acitretin in patients with psoriasis. Shalom G; Zisman D; Harman-Boehm I; Biterman H; Greenberg-Dotan S; Polishchuk I; Moser H; Freud T; Feldhamer I; Cohen AD Acta Derm Venereol; 2015 Nov; 95(8):973-7. PubMed ID: 25950855 [TBL] [Abstract][Full Text] [Related]
13. Systemic Treatment of Recalcitrant Pediatric Psoriasis: A Case Series and Literature Review. Garber C; Creighton-Smith M; Sorensen EP; Dumont N; Gottlieb AB J Drugs Dermatol; 2015 Aug; 14(8):881-6. PubMed ID: 26267734 [TBL] [Abstract][Full Text] [Related]
14. Comparative tolerability of systemic treatments for plaque-type psoriasis. McClure SL; Valentine J; Gordon KB Drug Saf; 2002; 25(13):913-27. PubMed ID: 12381213 [TBL] [Abstract][Full Text] [Related]
15. Patients with moderate-to-severe plaque psoriasis preferred oral therapies to phototherapies: a preference assessment based on clinical scenarios with trade-off questions. Opmeer BC; Heydendael VM; deBorgie CA; Spuls PI; Bossuyt PM; Bos JD; de Rie MA J Clin Epidemiol; 2007 Jul; 60(7):696-703. PubMed ID: 17573985 [TBL] [Abstract][Full Text] [Related]
17. [News on psoriasis from the 2010 Dermatology Days in Paris]. Boulinguez S Ann Dermatol Venereol; 2011 May; 138(5 Suppl 1):H1-5. PubMed ID: 21703458 [No Abstract] [Full Text] [Related]
18. Sequential therapy using cyclosporine and acitretin for treatment of total body psoriasis. Short MW; Vaughan TK Cutis; 2004 Sep; 74(3):185-8. PubMed ID: 15499760 [TBL] [Abstract][Full Text] [Related]
19. Biologic and Conventional Systemic Therapies Show Similar Safety and Efficacy in Elderly and Adult Patients With Moderate to Severe Psoriasis. Garber C; Plotnikova N; Au SC; Sorensen EP; Gottlieb A J Drugs Dermatol; 2015 Aug; 14(8):846-52. PubMed ID: 26267729 [TBL] [Abstract][Full Text] [Related]